Chief Operating Officer · Verrica Pharmaceuticals Inc. · Common Stock
Side
BUY
Value
$30K
Shares
6,000
Price
$4.98
Executed
Aug 17, 2026
Disclosed
Aug 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 17 executedAug 18, 2026 disclosed
VRCA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zawitz David filed this Form 4 reporting a open-market purchase of VRCA on Aug 17, 2026. It became public on Aug 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Operating Officer
Zawitz Davidcik:0002046750
Issuer
Verrica Pharmaceuticals Inc.cik:0001660334
Revision history · 0
No field has changed since this record was first ingested.
